Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors

Conditions:   Solid Tumor;   Gastric Cancer;   Pancreatic Adenocarcinoma Intervention:   Drug: AB011 Injection Sponsors:   Carsgen Therapeutics, Ltd.;   Shanghai East Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials